Emvision Medical Devices Ltd Cash Flow Conversion Efficiency
Emvision Medical Devices Ltd cash flow conversion efficiency. Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.94 Million ≈ $-4.20 Million USD) by net assets (AU$19.74 Million ≈ $13.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Emvision Medical Devices Ltd (2018–2025)
Cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EMV stock price and chart for real-time trading data and today's change.
Emvision Medical Devices Ltd Cash Flow Conversion Ratio Explained
Emvision Medical Devices Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency. Also see EMV stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kizilbuk Gayrimenkul Yatirim Ortakligi AS
IS:KZBGY
|
0.029x |
|
Microcosm Technology Co Ltd
TWO:3354
|
-0.025x |
|
Finance of America Companies Inc
NYSE:FOA
|
0.000x |
|
Atturra Ltd
AU:ATA
|
-0.061x |
|
Western Energy Services Corp.
TO:WRG
|
0.027x |
|
Red Planet Indonesia Tbk
JK:PSKT
|
0.009x |
|
GENOR BIOPHARMA DL-00002
F:67N0
|
N/A |
|
NextEye Co. Ltd
KQ:137940
|
-0.144x |
Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. Review EMV cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$9.28 Million ≈ $6.57 Million |
AU$-7.84 Million ≈ $-5.54 Million |
-0.844x | -160.85% |
| 2024-06-30 | AU$18.52 Million ≈ $13.10 Million |
AU$-5.99 Million ≈ $-4.24 Million |
-0.324x | -298.43% |
| 2023-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$834.15K ≈ $590.22K |
0.163x | +130.53% |
| 2022-06-30 | AU$7.08 Million ≈ $5.01 Million |
AU$-3.78 Million ≈ $-2.68 Million |
-0.534x | -19.47% |
| 2021-06-30 | AU$10.05 Million ≈ $7.11 Million |
AU$-4.49 Million ≈ $-3.18 Million |
-0.447x | +24.14% |
| 2020-06-30 | AU$5.52 Million ≈ $3.91 Million |
AU$-3.26 Million ≈ $-2.30 Million |
-0.589x | -22.46% |
| 2019-06-30 | AU$4.60 Million ≈ $3.26 Million |
AU$-2.22 Million ≈ $-1.57 Million |
-0.481x | +9.42% |
| 2018-06-30 | AU$1.28 Million ≈ $905.05K |
AU$-679.59K ≈ $-480.85K |
-0.531x | -- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more